论文部分内容阅读
目的探索影响急性白血病长期生存的因素。方法对急性白血病患者诱导缓解期采用强烈而有效的联合化疗，并实行个体化用药原则，坚持缓解后正规的巩固强化治疗，长期随访观察，根据情况调整用药方案。结果急性白血病２６９例中达到完全缓解２０２例（７５％），３ａ以上长期生存３４例（１７％）。结论影响急性白血病长期生存的主要因素为急性白血病类型、个体化治疗、达到完全缓解的时间长短、正规的缓解后治疗等。
Objective To explore the factors that affect the long-term survival of acute leukemia. Methods A strong and effective combination chemotherapy was used for the induction of remission in patients with acute leukemia, and the principle of individualized medication was applied. After the remission, regular consolidation and intensive treatment were adhered to. Long-term follow-up observations were made, and the medication plan was adjusted according to the situation. RESULTS: Acute leukemia achieved complete remission in 202 cases (75%) and long-term survival in 3 years or longer (34 cases, 17%). Conclusion The main factors affecting the long-term survival of acute leukemia are the type of acute leukemia, individualized treatment, the length of time to achieve complete remission, and regular post-remission treatment.